Barclays’s Signify Health, Inc. SGFY Stock Holding History

Barclays’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-75,143	Closed	-$2.15M	–	5498
2022 Q4	$2.15M	Sell	75,143 -17,176	-19%	-$496K	﹤0.01%	2217
2022 Q3	$2.69M	Buy	92,319 +53,892	+140%	+$1.24M	﹤0.01%	1542
2022 Q2	$530K	Sell	38,427 -28,253	-42%	-$398K	﹤0.01%	2807
2022 Q1	$1.21M	Buy	+66,680	New	+$956K	﹤0.01%	2257

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Barclays's SGFY Position: Q1 2023 in Review

Barclays sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 75,143 shares — an estimated $2.15M sold.

Barclays first reported a position in SGFY in Q1 2022 and held it in 4 quarters. The position peaked at $2.69M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Barclays reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Barclays sold 75,143 Signify Health, Inc. shares in Q1 2023, an estimated $2.15M.
Barclays first reported a position in Signify Health, Inc. in Q1 2022 and held it in 4 quarters.
Barclays's Signify Health, Inc. position peaked at $2.69M in Q3 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.